Amphotericin B use in children: conventional and lipid-based formulations. - Wikidata - wikimedia - TriplyDB

Amphotericin B use in children: conventional and lipid-based formulations.

Amphotericin B use in children: conventional and lipid-based formulations.

http://www.wikidata.org/entity/Q37854727

about

In vitro and in vivo evidence for amphotericin B as a P-glycoprotein substrate on the blood-brain barrier.Epidemiology and prognosis of candidaemia in elderly patients.Pediatric invasive fungal infections: realities, challenges, concerns, myths and hopes.

P2860

Q34058209-2B7E4699-2E99-4541-AC0D-2BEF26B65980 Q40072606-D747A977-7959-4346-9470-E7FD202EC546 Q43425305-7E9CF391-49E8-4CA0-A831-A010B38A7536

P2860

Amphotericin B use in children: conventional and lipid-based formulations.

http://www.wikidata.org/entity/Q37854727

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Amphotericin B use in children: conventional and lipid-based formulations.

@en

Amphotericin B use in children: conventional and lipid-based formulations.

@nl

type

label

Amphotericin B use in children: conventional and lipid-based formulations.

@en

Amphotericin B use in children: conventional and lipid-based formulations.

@nl

prefLabel

Amphotericin B use in children: conventional and lipid-based formulations.

@en

Amphotericin B use in children: conventional and lipid-based formulations.

@nl

P1433

Q37854727-37607F7C-F9D1-43A2-865B-18F0FCDF733E

P1476

Q37854727-AF9E91D9-4EA4-40E7-AD9B-9ABCEFFD595B

P2093

Q37854727-D68BB406-7E32-413C-9CCD-58B3C2B9AA1C

P2860

Q37854727-013DAA24-B44B-4E3C-A78B-E1E1357B2040

Q37854727-04E161F7-A418-4CB8-98F8-7C95964CD471

Q37854727-0699E775-DC2F-4A5C-B4A7-9510C710BB94

Q37854727-087E33EC-9F62-40A0-889A-A8C8A263E5D1

Q37854727-0AC7D691-C972-4D2C-9C9D-A39356AAB755

Q37854727-0BA3D072-8CD8-47FA-806B-EB8925BDEF88

Q37854727-0D06CA04-C77B-4451-9154-411E55FA1426

Q37854727-0D11447E-7383-44A7-9ED1-7D2531D8A056

Q37854727-119DC683-C9DE-46B9-81AD-D4191892A9BC

Q37854727-16FB199E-5AB7-464F-A20D-A2A0C87B5FD8

P304

Q37854727-7E7D2730-B22C-47F2-8DDB-9CC6ACB3B9F8

P31

Q37854727-264EB766-0024-4B64-909B-F09B417EFDE0

P356

Q37854727-5403E9B0-2594-4224-BBF4-51AE15BB78EC

P433

Q37854727-0A713B81-F1D8-4344-969E-2A8CB5215464

P478

Q37854727-BD32A9BD-7A92-4FBD-B835-E1C5324BF1B7

P577

Q37854727-F1B905F1-1850-41A6-A882-E06434AB9477

P698

Q37854727-03D0E6B0-4651-465E-800D-175C269876BE

P356

P1433

Expert Review of Anti-infective Therapy

P1476

Amphotericin B use in children: conventional and lipid-based formulations.

@en

P2093

Necdet Kuyucu

http://www.w3.org/2001/XMLSchema#string

P2860

Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases

Histoplasmosis: a clinical and laboratory update

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.

Lipid-based amphotericin B for the treatment of fungal infections.

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.

Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system.

P304

357-367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERI.11.5

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21417875

http://www.w3.org/2001/XMLSchema#string